Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Clinical Trial

Evaluation of a Nutraceutical Product with Probiotics, Vitamin D, Plus Banaba Leaf Extracts (Lagerstroemia speciosa) in Glycemic Control

Author(s): Luca Signorini, Andrea Ballini*, Roberto Arrigoni*, Francesco De Leonardis, ">Rajiv Saini, ">Stefania Cantore, Danila De Vito, Maria Franca Coscia, Gianna Dipalma, Luigi Santacroce and Francesco Inchingolo

Volume 21, Issue 7, 2021

Published on: 09 November, 2020

Page: [1356 - 1365] Pages: 10

DOI: 10.2174/1871530320666201109115415

Price: $65

Abstract

Background: Dysbiosis is related to changes in the composition and behaviour of intestinal microbiota, which may contribute to an age-related decline in metabolic and immune system functioning (immune-senescence).

Objective: The microbiota-targeted dietary and probiotic interventions have been shown to favorably affect the host health by an enhancement of antioxidant activity, improving immune homeostasis, suppression of chronic inflammation, regulation of metabolism and prevention of insulin resistance.

Results: In our study, the use of specific probiotics strains improved the serum concentration of glycemic markers, thereby promoting better overall health.

Conclusion: Probiotics may help correct defects in the gut microbial environment improving metabolic parameters, such as blood sugar levels, glycosylated hemoglobin and a decrease in body weight.

Keywords: Probiotics, translational medicine, Vitamin D, cholecalciferol, Banaba leaf extracts, Lagerstroemia speciosa.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy